| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 348.60B | 349.35B | 344.15B | 319.50B | 286.48B |
| Gross Profit | 56.98B | 54.29B | 52.48B | 40.04B | 38.91B |
| EBITDA | 37.37B | 35.94B | 37.06B | 24.81B | 23.34B |
| Net Income | 11.82B | 11.86B | 13.74B | 1.19B | 83.00M |
Balance Sheet | |||||
| Total Assets | 348.67B | 333.53B | 357.49B | 328.45B | 342.75B |
| Cash, Cash Equivalents and Short-Term Investments | 103.52B | 97.91B | 102.25B | 75.79B | 74.56B |
| Total Debt | 146.36B | 160.31B | 170.99B | 178.86B | 188.09B |
| Total Liabilities | 215.20B | 222.65B | 234.91B | 241.49B | 254.55B |
| Stockholders Equity | 119.83B | 95.70B | 101.64B | 66.77B | 68.02B |
Cash Flow | |||||
| Free Cash Flow | 17.20B | 29.24B | 31.13B | 19.75B | 770.00M |
| Operating Cash Flow | 28.61B | 38.02B | 41.51B | 29.62B | 12.00B |
| Investing Cash Flow | -11.68B | -6.88B | -5.24B | -9.17B | -6.84B |
| Financing Cash Flow | -17.29B | -33.92B | -13.79B | -20.68B | -13.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥401.23B | 8.31 | 8.36% | 2.71% | 2.88% | 213.02% | |
81 Outperform | ¥240.16B | 8.29 | ― | 3.36% | 4.89% | 43.96% | |
74 Outperform | ¥537.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
72 Outperform | ¥149.58B | 16.02 | ― | 2.93% | 3.63% | 35.38% | |
70 Outperform | ¥780.69B | 40.50 | 7.20% | 2.41% | 3.37% | -62.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥57.98B | 3.06 | ― | 0.99% | -0.22% | -2.98% |